Recent Finacing
Recent Raise
AmnioChor develops perinatal stem cell technologies and products AmnioCept and OmniBank for cryopreserving amniotic membrane and resident epithelial/mesenchymal cells to augment cord blood and support tissue engineering.
Focus Areas
Recent Investors
Funding round
Investor